A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemo-Radiotherapy in the Adjuvant Setting in Operated Patients with HER2+Gastric or Gastroesophageal Junction Cancer (TOXAG Study)

Abali, HuseyinYalcin, SuayibOnal, CemDane, FaysalOksuzoglu, BernaOzdemir, NuriyeMertsoylu, HuseyinArtac, MehmetCamci, CelaletdinKarabulut, BulentBasal, Fatma BugdayciBudakoglu, BurcinSendur, Mehmet Ali NahitGoktas, BurceOzdener, FatihBaygul, Arzu2023-04-242023-04-2420180732-183Xhttp://hdl.handle.net/11727/8857enginfo:eu-repo/semantics/closedAccessA Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemo-Radiotherapy in the Adjuvant Setting in Operated Patients with HER2+Gastric or Gastroesophageal Junction Cancer (TOXAG Study)conferenceObject364000436174100026